TY - JOUR
T1 - Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center
AU - Hoversten, Patrick
AU - Otaki, Fouad
AU - Katzka, David A.
N1 - Publisher Copyright:
© 2019 AGA Institute
PY - 2019/1
Y1 - 2019/1
N2 - Candida infection in the gastrointestinal tract is most studied in immunocompromised patients. Patients without systemic immunodeficiency, however, may have esophageal candidiasis associated with antibiotic or steroid medication use, alcoholic consumption, diabetes mellitus, and esophageal stasis disorders such achalasia or scleroderma esophagus.1–5 This population has not been well studied. We aim to describe demographics, risk factors, and relevant clinical outcomes for patients with Candida esophagitis with an emphasis in systemically immunocompetent patients.
AB - Candida infection in the gastrointestinal tract is most studied in immunocompromised patients. Patients without systemic immunodeficiency, however, may have esophageal candidiasis associated with antibiotic or steroid medication use, alcoholic consumption, diabetes mellitus, and esophageal stasis disorders such achalasia or scleroderma esophagus.1–5 This population has not been well studied. We aim to describe demographics, risk factors, and relevant clinical outcomes for patients with Candida esophagitis with an emphasis in systemically immunocompetent patients.
UR - http://www.scopus.com/inward/record.url?scp=85057226533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057226533&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2018.04.035
DO - 10.1016/j.cgh.2018.04.035
M3 - Short survey
C2 - 29702297
AN - SCOPUS:85057226533
SN - 1542-3565
VL - 17
SP - 200-202.e1
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 1
ER -